Home » Authors » Jim Shrine

Articles by Jim Shrine

Celldex Starts Phase II/III Trial Of Peptide Vaccine In Brain Cancer

May 25, 2007

NewCo News: Arete Completes $51M Round For New Hypertension Class

May 24, 2007

Genomic Health raises $46.5M to push personalized medicine

May 24, 2007

Phase Forward offering at $90M; Genomic Health raises $45 million

May 24, 2007

NewCo News: Arete Completes $51M Round For New Hypertension Class

May 24, 2007

Genomic Health Raises $46.5M For Personalized Diagnostics

May 23, 2007

Genomic Health Raises $46.5M For Personalized Diagnostics

May 23, 2007

Eurand Raises $112M In IPO For Internal, Collaborative Programs

May 18, 2007

Eurand Raises $112M In IPO For Internal, Collaborative Programs

May 18, 2007

Marcadia Raises $15M In First Round For Metabolic Programs

May 16, 2007

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 8, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 8, 2025.
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...
Brenig Therapeutics discovers new LRRK2 inhibitors
BioWorld Science
Brenig Therapeutics Inc. has described leucine-rich repeat kinase 2 (LRRK2; dardarin) and (LRRK2; dardarin) (G2019S mutant) inhibitors reported to be useful for...